# Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial

> **NCT01441427** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 93 (actual)

## Conditions studied

- Feeding Intolerance
- Necrotizing Enterocolitis

## Interventions

- **DRUG:** recombinant human G-CSF, and rhEPO
- **DRUG:** rh G-CSF
- **DRUG:** rh EPO
- **DRUG:** rh G-GSF and rh EPO together
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01441427
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-08
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2011-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441427, "Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01441427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*